Jeffrey A. Leerink is Chairman and Chief Executive Officer of LEERINK Partners, a healthcare investment bank that helps advance healthcare innovations that improve the global healthcare system.
Mr. Leerink founded the firm in 1995 and under his leadership, LEERINK has grown to become a leading healthcare investment bank and company building partner. The firm is focused on providing differentiated healthcare knowledge and equity capital markets, equity research, and mergers and acquisitions expertise to help its clients define and achieve their strategic and capital markets objectives. In 2008, Mr. Leerink co-founded and was a member of the Board of Directors of Humedica, a clinical intelligence company that was incubated at LEERINK. In 2013, Humedica was acquired by Optum, a subsidiary of UnitedHealth Group. Leerink Capital Partners, the asset management affiliate of LEERINK Partners, was formed in 2013 to build and lead a multi-strategy, healthcare-focused principal investment business with a dedicated team experienced in originated, structuring and managing healthcare investments.
Currently, Mr. Leerink is a member of the Harvard Medical School Board of Fellows and is a member of the New England Chapter of CEO’s Against Cancer serving as Vice Chair. He is also a board member at Big Brother Big Sister of Massachusetts Bay having served as Chairman of the Board from 2013 – 2016. Additionally, Mr. Leerink serves as a board member at FogPharma.
Mr. Leerink holds a B.A. in Economics from Union College.